Cost utility analysis of deferasiroxversus deferoxamine for patients requiring iron chelation therapy in the United Kingdom

被引：0
作者：
Karnon, J.
Akehurst, R. L.
Jewitt, K.
Ossa, D.
机构：
[1] Univ Sheffield, Sheffield, S Yorkshire, England
[2] Novartis Plc, Camberley, England
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0598
引用
收藏
页码：222 / 223
页数：2
相关论文
共 50 条
  • [1] Cost-utility analysis of deferasirox compared to standard therapy with desferrioxamine for patients requiring iron chelation therapy in the United Kingdom
    Karnon, J.
    Tolley, K.
    Oyee, J.
    Jewitt, K.
    Ossa, D.
    Akehurst, R.
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (06) : 1609 - 1621
  • [2] IRON CHELATION THERAPY WITH DEFEROXAMINE IN COOLEY ANEMIA
    COHEN, A
    SCHWARTZ, E
    JOURNAL OF PEDIATRICS, 1978, 92 (04) : 643 - 647
  • [3] Burden of current iron chelation therapy in treatment centres in the United Kingdom
    Payne, K. A.
    Desrosiers, M.-P.
    Proskorovsky, I.
    Ishak, K.
    Rofail, D.
    Baladi, J.-F.
    ANNALS OF ONCOLOGY, 2006, 17 : 204 - 204
  • [4] CURRENT STATUS OF IRON CHELATION-THERAPY WITH DEFEROXAMINE
    COHEN, A
    SEMINARS IN HEMATOLOGY, 1990, 27 (02) : 86 - 90
  • [5] Cost-effectiveness analysis of oral iron chelation therapy with deferasirox (Exjade®, ICL670) versus infusional chelation therapy with deferoxamine in patients with transfusion-dependent myelodysplastic
    Delea, TE
    Thomas, SK
    Baladi, JF
    Phatak, PD
    BLOOD, 2005, 106 (11) : 484B - 485B
  • [6] Deferoxamine (DFO) iron chelation therapy for childhood cancer.
    Frantz, CN
    Eskenazi, AE
    Overman, D
    Fan, L
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 475 - 475
  • [7] Safety and efficacy of combining deferiprone and deferoxamine in iron chelation therapy in patients with thalassemia.
    Kattamis, A
    Kassou, C
    Ladis, V
    Berdoussi, H
    Papasotiriou, I
    Kattamis, C
    BLOOD, 2002, 100 (11) : 120A - 120A
  • [8] LIVER IRON STORES IN PATIENTS WITH SECONDARY HEMOSIDEROSIS UNDER IRON CHELATION-THERAPY WITH DEFEROXAMINE OR DEFERIPRONE
    NIELSEN, P
    FISCHER, R
    ENGELHARDT, R
    TONDURY, P
    GABBE, EE
    JANKA, GE
    BRITISH JOURNAL OF HAEMATOLOGY, 1995, 91 (04) : 827 - 833
  • [9] The real cost of iron chelation therapy
    Pavenski, Katerina
    Quirt, Ian
    TRANSFUSION, 2007, 47 (10) : 1751 - 1752
  • [10] Iron chelation with deferoxamine improves endothelial function in patients with atherosclerosis
    Duffy, SJ
    Biegelsen, ES
    Jewett, TA
    Holbrook, M
    Keaney, JF
    Vita, JA
    CIRCULATION, 1999, 100 (18) : 756 - 756
12345